Literature DB >> 11782927

Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.

Jun Kato1, Naoya Kato, Hideo Yoshida, Suzane Kioko Ono-Nita, Yasushi Shiratori, Masao Omata.   

Abstract

Many viruses can inhibit protein synthesis in their host cells by targeting translation ("translational shutoff"). There are few reports on the effects of hepatitis C virus (HCV) infection on protein synthesis, because of the lack of a reproducible tissue culture system for HCV. In this study, the influence of seven HCV proteins (core, NS2, NS3, NS4A, NS4B, NS5A, NS5B) on protein synthesis was examined using a reporter assay. In addition, it was determined whether the HCV proteins inhibit protein synthesis via transcription or translation using an RNase protection assay and the effect of HCV proteins on translation from the HCV internal ribosome entry site (IRES) was also examined using a bicistronic reporter. Of the seven HCV proteins, NS4A and NS4B proteins inhibited cellular protein synthesis by targeting the process of translation. They also inhibited translation from the HCV IRES. Moreover, NS4A protein, induced under the control of doxycycline, inhibited the proliferation of HeLa cells. In conclusion, HCV NS4A and NS4B proteins have an effect of translational inhibition. This novel function may be involved in HCV infection and help its survival in host cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782927     DOI: 10.1002/jmv.2129

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  26 in total

1.  The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly.

Authors:  Tung Phan; Andrew Kohlway; Peniel Dimberu; Anna Marie Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

2.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.

Authors:  Zhengxian Gu; Jason D Graci; Frederick C Lahser; Jamie J Breslin; Stephen P Jung; James H Crona; Patricia McMonagle; Ellen Xia; Shaotang Liu; Gary Karp; Jin Zhu; Song Huang; Amin Nomeir; Marla Weetall; Neil G Almstead; Stuart W Peltz; Xiao Tong; Robert Ralston; Joseph M Colacino
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

4.  ACH-806, an NS4A antagonist, inhibits hepatitis C virus replication by altering the composition of viral replication complexes.

Authors:  Wengang Yang; Yongnian Sun; Xiaohong Hou; Yongsen Zhao; Joanne Fabrycki; Dawei Chen; Xiangzhu Wang; Atul Agarwal; Avinash Phadke; Milind Deshpande; Mingjun Huang
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

5.  An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication.

Authors:  Menashe Elazar; Ping Liu; Charles M Rice; Jeffrey S Glenn
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Topology of the membrane-associated hepatitis C virus protein NS4B.

Authors:  Marika Lundin; Magnus Monné; Anders Widell; Gunnar Von Heijne; Mats A A Persson
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Allelic variation in the hepatitis C virus NS4B protein dramatically influences RNA replication.

Authors:  Keril J Blight
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

8.  Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain.

Authors:  Jolanda M P Liefhebber; Bernd W Brandt; Rene Broer; Willy J M Spaan; Hans C van Leeuwen
Journal:  Virol J       Date:  2009-05-25       Impact factor: 4.099

9.  Refractoriness of hepatitis C virus internal ribosome entry site to processing by Dicer in vivo.

Authors:  Dominique L Ouellet; Isabelle Plante; Vincent Boissonneault; Cherifa Ayari; Patrick Provost
Journal:  J Negat Results Biomed       Date:  2009-08-13

10.  Hepatitis C virus NS4 protein impairs the Th1 polarization of immature dendritic cells.

Authors:  A Takaki; M Tatsukawa; Y Iwasaki; K Koike; Y Noguchi; H Shiraha; K Sakaguchi; E Nakayama; K Yamamoto
Journal:  J Viral Hepat       Date:  2009-10-04       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.